Company / Operating Income per Share
NEKTAR THERAPEUTICS Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$11.31
FY2025
5-year range
-$11.31 / -$1.38
FY2021-FY2025
Trend
-721.1%
vs FY2024
Sector context
#196 of 201
Health Care
What the data says
Operating Income per Share changed -721% YoY in FY2025, a notable deviation from the 9-year average annual change of +16%.
Based on SEC 10-K filings.
-11.31 in FY2025.
Declined from $-2.37 to $-11.31 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 201This company -$11.31 Sector average -$3.23
▼
-249.8% below sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 721.1% year-over-year.
- Ranks #196 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -11.97 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$11.31 | -721.1% |
| FY2024 | -$1.38 | +41.8% |
| FY2023 | -$2.37 | -16.6% |
| FY2022 | -$2.03 | +18.1% |
| FY2021 | -$2.48 | -163.6% |
| FY2020 | $3.90 | +1234.0% |
| FY2019 | -$0.34 | +51.4% |
| FY2018 | -$0.71 | -81.7% |
| FY2017 | -$0.39 | -219.5% |
| FY2016 | -$0.12 | +45.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026